ConvaTec Group (LON:CTEC) Insider Purchases £100,500 in Stock

ConvaTec Group PLC (LON:CTEC) insider Jonny Mason bought 50,000 shares of the company’s stock in a transaction that occurred on Tuesday, May 26th. The stock was purchased at an average price of GBX 201 per share, with a total value of £100,500.

Jonny Mason also recently made the following trade(s):

• On Monday, March 16th, Jonny Mason sold 291,149 shares of ConvaTec Group stock. The stock was sold at an average price of GBX 234, for a total value of £681,288.66.

ConvaTec Group Stock Performance

LON:CTEC opened at GBX 204.98 on Wednesday. The business has a 50 day moving average of GBX 219.11 and a 200 day moving average of GBX 229.95. The company has a market capitalization of £4.01 billion, a price-to-earnings ratio of 23.83, a PEG ratio of 0.93 and a beta of 0.78. ConvaTec Group PLC has a 1-year low of GBX 195.90 and a 1-year high of GBX 311.20. The company has a debt-to-equity ratio of 106.19, a current ratio of 1.53 and a quick ratio of 0.96.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on CTEC. Stifel Nicolaus restated a “buy” rating and issued a GBX 315 target price on shares of ConvaTec Group in a research report on Wednesday, March 11th. Berenberg Bank reiterated a “buy” rating and issued a GBX 340 price objective on shares of ConvaTec Group in a research report on Tuesday, April 21st. UBS Group reiterated a “buy” rating and issued a GBX 375 price objective on shares of ConvaTec Group in a research report on Monday, May 18th. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a GBX 315 price objective on shares of ConvaTec Group in a research report on Wednesday, April 8th. Finally, Citigroup lowered their price objective on ConvaTec Group from GBX 250 to GBX 230 and set a “neutral” rating for the company in a research report on Monday, May 18th. Eight research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to MarketBeat.com, ConvaTec Group has an average rating of “Moderate Buy” and a consensus price target of GBX 308.78.

ConvaTec Group Company Profile

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer.